Current biochemical studies of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) suggest a new therapeutic approach.
Hookman
Perry
P
University of Miami School of Medicine, Mount Sinai Medical Center, Division of Gastroenterology, Florida, USA.
Barkin
Jamie S
JS
D000818:Animals; D005234:Fatty Liver / Q000188:drug therapy* / Q000378:metabolism*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008297:Male; D008687:Metformin / Q000627:therapeutic use*; D051379:Mice; D008820:Mice, Obese
D007004:Hypoglycemic Agents; D008687:Metformin